CareStart 

Self Test for SARS-CoV-2 Antigen Detection

Current Stamped Expiration Date: January 01, 2026

The CareStart™ COVID-19 Antigen Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2. Under FDA’s EUA, CareStart™ COVID-19 Antigen Home Test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal (nares) swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older, or adult-collected anterior nasal (nares) swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests.

Install the App For Easy Use

Our mobile app for iOS and Android is simple to use and provides a straightforward testing experience. The On/Go app (for use with On/Go and CareStart At Home Tests) gives you instant test results, keeps track of your testing history, and makes it simple to communicate results with those who need to know.

For use under Emergency Use Authorization Only

For In Vitro Diagnostic Use Only

Fast and easy to self-test at anywhere

Easy to interpret the results using mobile application

Qualitatively detect the SARS-CoV-2 nucleocapsid protein

Use for nasal swab specimen

Fast results only in 10 minutes

Identify individual’s current infection status to COVID-19

iOS13 or newer for Apple iPhone

Android10 or newer for Android Phone